Survival outcomes and treatment costs for patients with double-refractory chronic lymphocytic leukaemia (DR-CLL).

Publication

Survival outcomes and treatment costs for patients with double-refractory chronic lymphocytic leukaemia (DR-CLL).

Bloor, Adrian
;
De Cock, E
;
Hatswell, A
;
Wasiak, R
;
Elvidge, J
;
Stapelkamp, C
;
Hadjivassileva, T
;
Haiderali, A
;
Delgado, J

Authors

Bloor, Adrian
De Cock, E
Hatswell, A
Wasiak, R
Elvidge, J
Stapelkamp, C
Hadjivassileva, T
Haiderali, A
Delgado, J

Affiliation

Department of Haematology, The Christie NHS Foundation Trust, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK.

Date

2014-11-20

Collections

All Christie Publications

Show all metadata

Type

Article

Citation

Survival outcomes and treatment costs for patients with double-refractory chronic lymphocytic leukaemia (DR-CLL). 2014: Br J Haematol

URI

http://hdl.handle.net/10541/336213